We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$1.28B
AUM Growth
+$202M
Cap. Flow
+$135M
Cap. Flow %
10.6%
Top 10 Hldgs %
59.27%
Holding
223
New
41
Increased
76
Reduced
74
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 10.18%
2 Financials 2.73%
3 Communication Services 2.38%
4 Healthcare 1.68%
5 Consumer Staples 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOM icon
26
iShares Core Moderate Allocation ETF
AOM
$1.75B
$7.86M 0.61%
191,360
-9,553
-5% -$392K
VTI icon
27
Vanguard Total Stock Market ETF
VTI
$655B
$7.58M 0.59%
44,541
-1,478
-3% -$249K
USMV icon
28
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
$6.91M 0.54%
108,409
-37,570
-26% -$2.38M
GOOGL icon
29
Alphabet (Google) Class A
GOOGL
$3.99T
$6.54M 0.51%
89,240
+4,780
+6% +$364K
CVX icon
30
Chevron
CVX
$378B
$6.05M 0.47%
84,095
+70,951
+540% +$5.97M
JPM icon
31
JPMorgan Chase
JPM
$947B
$5.89M 0.46%
61,200
+38,510
+170% +$3.78M
VWO icon
32
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$5.75M 0.45%
132,762
+1,737
+1% +$75.5K
EEM icon
33
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$4.74M 0.37%
107,428
-991
-0.9% -$43.5K
VTEB icon
34
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
$4.62M 0.36%
84,766
-4,200
-5% -$229K
VGT icon
35
Vanguard Information Technology ETF
VGT
$138B
$4.58M 0.36%
117,704
-520
-0.4% -$19.6K
JNJ icon
36
Johnson & Johnson
JNJ
$641B
$4.33M 0.34%
29,109
+4,313
+17% +$638K
IWD icon
37
iShares Russell 1000 Value ETF
IWD
$81.5B
$4.26M 0.33%
36,066
-12,663
-26% -$1.5M
IWV icon
38
iShares Russell 3000 ETF
IWV
$19.5B
$4.24M 0.33%
21,627
-104
-0.5% -$20.1K
VEA icon
39
Vanguard FTSE Developed Markets ETF
VEA
$227B
$3.97M 0.31%
97,140
-6,023
-6% -$247K
CSCO icon
40
Cisco
CSCO
$452B
$3.96M 0.31%
100,576
+78,921
+364% +$3.44M
SCHX icon
41
Schwab US Large- Cap ETF
SCHX
$71.1B
$3.95M 0.31%
294,258
-1,698
-0.6% -$22.6K
INTC icon
42
Intel
INTC
$462B
$3.94M 0.31%
76,012
+57,391
+308% +$2.98M
DOCU
43
DocuSign
DOCU
$10.1B
$3.6M 0.28%
16,739
MRK icon
44
Merck
MRK
$323B
$3.51M 0.27%
44,344
+30,990
+232% +$2.43M
VZ icon
45
Verizon
VZ
$198B
$3.32M 0.26%
55,776
+37,250
+201% +$2.16M
OXY icon
46
Occidental Petroleum
OXY
$54.6B
$3.24M 0.25%
+323,512
New +$4.56M
VCSH icon
47
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$3.19M 0.25%
38,548
-2,812
-7% -$233K
EFAV icon
48
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.26B
$3.18M 0.25%
46,689
-33,577
-42% -$2.29M
GOOG icon
49
Alphabet (Google) Class C
GOOG
$3.99T
$3.15M 0.25%
42,920
-20
-0% -$1.53K
AMZN icon
50
Amazon
AMZN
$2.49T
$3.13M 0.24%
19,860
+3,100
+18% +$489K

Similar funds

Aspiriant LLC's Q3 2020 Portfolio in Review

As of Q3 2020, Aspiriant LLC held 223 positions worth $1.28B, up 19% from $1.08B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Aspiriant LLC deployed $135M of net new capital in Q3 2020, opening 41 new positions and adding to 76 existing holdings. Its largest new stake was Occidental Petroleum: 323,512 shares worth $3.24M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 5.6% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $5.03M trimmed.

  • Aspiriant LLC's largest Q3 2020 buy was Occidental Petroleum: 323,512 shares worth $3.24M.
  • Aspiriant LLC added most to iShares Core S&P US Value ETF in Q3 2020, an estimated $49.1M increase.
  • Aspiriant LLC's biggest Q3 2020 reduction was iShares National Muni Bond ETF, cutting an estimated $5.03M.
  • Aspiriant LLC fully exited Illumina in Q3 2020, selling an estimated $644K.
  • Aspiriant LLC's ten largest holdings make up 59% of its $1.28B portfolio in Q3 2020.
  • Aspiriant LLC opened 41 new positions and closed 7 in Q3 2020.
  • Aspiriant LLC's portfolio value rose 19% quarter-over-quarter to $1.28B.

Based on Aspiriant LLC's 13F filing for Q3 2020, filed 29 Oct 2020.